Your browser doesn't support javascript.
loading
Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation.
Tang, Ke; McLeod, Louise; Livis, Thaleia; West, Alison C; Dawson, Ruby; Yu, Liang; Balic, Jesse J; Chonwerawong, Michelle; Wray-McCann, Georgie; Oshima, Hiroko; Oshima, Masanobu; Deswaerte, Virginie; Ferrero, Richard L; Jenkins, Brendan J.
Affiliation
  • Tang K; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • McLeod L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Livis T; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • West AC; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Dawson R; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Yu L; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Balic JJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Chonwerawong M; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Wray-McCann G; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Oshima H; Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Oshima M; Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Deswaerte V; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
  • Ferrero RL; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia; Biomedicine Discovery Institute, D
  • Jenkins BJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Molecular Translational Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia. Electronic address: Brendan.Jenkin
Cell Mol Gastroenterol Hepatol ; 14(3): 567-586, 2022.
Article in En | MEDLINE | ID: mdl-35716851

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Helicobacter pylori / Helicobacter Infections / Gastritis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2022 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Helicobacter pylori / Helicobacter Infections / Gastritis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2022 Type: Article Affiliation country: Australia